Pfizer Europe MA EEIG
PolandAll drugs from this manufacturer
-
The medicine is used for the symptomatic treatment of osteoarthritis and rheumatoid arthritis. It contains ingredients that help protect the stomach and duodenum from damage caused by anti-inflammatory drugs.
Dosage form: tablets, enteric-coated
Active substance Dosage sodium diclofenac 75 mg misoprostol 0.2 mg ATC: M01AB55
-
The medicine is used to relieve pain associated with functional disorders of the gastrointestinal tract and bile ducts, and to correct motility disorders and intestinal complaints.
Dosage form: powder for preparation of oral suspension
Active substance Dosage trimebutine 7.87 mg/g ATC: A03AA05
-
The medicine is used to relieve intestinal disorders and pain associated with functional disorders of the gastrointestinal tract and bile ducts.
Dosage form: tablets, film-coated
Active substance Dosage trimebutine maleate 100 mg ATC: A03AA05
-
The medicine is used to relieve intestinal dysfunction and pain associated with functional disorders of the gastrointestinal tract and bile ducts.
Dosage form: tablets, film-coated
Active substance Dosage trimebutine maleate 100 mg ATC: A03AA05
-
The medicine is used to suppress lactation (milk production) after childbirth or to terminate it. It is also used to treat disorders related to excessive prolactin secretion (e.g., irregular menstruation, lack of ovulation) and in the treatment of pituitary adenoma.
Dosage form: tablets
Active substance Dosage cabergoline 0.5 mg ATC: G02CB03
-
The medicine is used to inhibit lactation (milk production) after childbirth or to interrupt it. It is also used in the treatment of disorders related to excessive prolactin secretion (e.g., irregular menstruation, lack of ovulation) and in the treatment of pituitary adenoma.
Dosage form: tablets
Active substance Dosage cabergoline 0.5 mg ATC: G02CB03
-
The medicine is used to inhibit lactation (milk production) after childbirth or to stop it. It is also used to treat disorders related to excessive prolactin secretion (e.g., irregular periods, lack of ovulation, galactorrhea) and in the treatment of pituitary adenoma and other conditions associated with high prolactin levels.
Dosage form: tablets
Active substance Dosage cabergoline 0.5 mg ATC: G02CB03
-
The medicine is used to inhibit lactation (milk production) after childbirth or to discontinue it. It is also used to treat disorders related to excessive prolactin secretion (e.g., irregular menstruation, lack of ovulation) and in the treatment of pituitary adenoma.
Dosage form: tablets
Active substance Dosage cabergoline 0.5 mg ATC: G02CB03
-
The medicine is used to inhibit lactation (milk production) after childbirth or to stop it. It is also used to treat disorders related to excessive prolactin secretion (e.g., absence of menstruation, absence of ovulation, galactorrhea) and in the treatment of pituitary adenoma.
Dosage form: tablets
Active substance Dosage cabergoline 0.5 mg ATC: G02CB03
-
The medicine is used to inhibit lactation after childbirth or to stop milk secretion. It is also intended for the treatment of disorders related to excessive prolactin secretion (e.g., irregular periods, lack of ovulation) and for the treatment of pituitary adenoma.
Dosage form: tablets
Active substance Dosage cabergoline 0.5 mg ATC: G02CB03